Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study

References

• GalloMFNandaKGrimesDASchulzKF20 mcg versus >20 mcg estrogen combined oral contraceptives for contraceptionCochrane Database Syst Rev20052CD00398915846690
   PubMed Web of Science ®Google Scholar
• GerstmanBBPiperJMTomitaDKFergusonWJStadelBVLundinFEOral contraceptive estrogen dose and the risk of deep venous throm-boembolic diseaseAm J Epidemiol1991133132371983896
   PubMed Web of Science ®Google Scholar
• SerupJBostofteELarsenSWestergaardJEffectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigationActa Obstet Gynecol Scand19816022032067018165
   PubMed Web of Science ®Google Scholar
• WenzlRBenninkHCvan BeekASponaJHuberJOvulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiolFertil Steril19936046166198405513
   PubMed Web of Science ®Google Scholar
• CarusoSIraciMCianciSCasellaEFavaVCianciAQuality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogestJ Endocrinol Invest201538111211121826337183
   PubMed Web of Science ®Google Scholar
• LaganaASVitaleSGGraneseRClinical dynamics of dienogest for the treatment of endometriosis: from bench to bedsideExpert Opin Drug Metab Toxicol201713659359628537213
   PubMed Web of Science ®Google Scholar
• LaganaASVitaleSGMusciaVEndometrial preparation with dienogest before hysteroscopic surgery: a systematic reviewArch Gynecol Obstet2017295366166727904953
   PubMed Web of Science ®Google Scholar
• Bayer HealthCare Pharmaceuticals IncNatazia^®: prescribing information2010 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022252s002lbl.pdfAccessed 25 October 2016
   Google Scholar
• Bayer PharmaAGQlaira^®: summary of product characteristics2010 Available from: http://qlaira.com/static/assets/SPC_nlh-1230-001.pdfAccessed 25 October 2016
   Google Scholar
• Government of CanadaNatazia^®: product monograph2015 Available from: https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do;jsessionid=8BDAB463F6A0BAFD94293937593EB9BFAccessed 25 October 2016
   Google Scholar
• Bayer Australia LimitedQlaira^® (oestradiol valerate/dienogest): product information2009 Available from: http://www.bayerresources.com.au/resources/uploads/PI/file9422.pdfAccessed 25 October 2016
   Google Scholar
• Singapore Government Health Sciences AuthorityQlaira film coated tablet2011 Available from: http://www.hsa.gov.sg/content/hsa/en/Health_Products_Regulation/Western_Medicines/New_Drug_Approvals/2011/September.html#QlairaAccessed 25 October 2016
   Google Scholar
• AhrendtHJMakalovaDParkeSMellingerUMansourDBleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrelContraception200980543644419835717
   PubMed Web of Science ®Google Scholar
• GerlingerCEndrikatJvan der MeulenEADiebenTODusterbergBRecommendation for confidence interval and sample size calculation for the Pearl IndexEur J Contracept Reprod Health Care200382879212836662
   PubMed Web of Science ®Google Scholar
• BelseyEMMachinDd’ArcanguesCThe analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human ReproductionContraception19863432532603539509
   PubMed Web of Science ®Google Scholar
• World Health OrganisationFamily planning/contraception: fact sheet no 3512015 Available from: http://www.who.int/mediacentre/factsheets/fs351/enAccessed June 15, 2016
   Google Scholar
• Najafi-SharjabadFZainiyah Syed YahyaSAbdul RahmanHHanafiah JuniMAbdul ManafRBarriers of modern contraceptive practices among Asian women: a mini literature reviewGlob J Health Sci201355181192
   PubMedGoogle Scholar
• JensenJTParkeSMellingerUSerraniMMabeyRGJrHormone withdrawal-associated symptoms: comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimateEur J Contracept Reprod Health Care201318427428323638631
   PubMed Web of Science ®Google Scholar
• NelsonAParkeSMellingerUZampaglioneESchmidtAEfficacy and safety of a combined oral contraceptive containing estradiol valerate/dienogest: results from a clinical study conducted in North AmericaJ Womens Health (Larchmt)201423320421024279594
   PubMed Web of Science ®Google Scholar
• PalaciosSWildtLParkeSMachlittARomerTBitzerJEfficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trialEur J Obstet Gynecol Reprod Biol20101491576219969409
   PubMed Web of Science ®Google Scholar
• EndrikatJParkeSTrummerDSchmidtWDuijkersIKlippingCOvulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studiesContraception200878321822518692612
   PubMed Web of Science ®Google Scholar
• TeichmannAApterDEmerichJContinuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trialContraception200980650451119913143
   PubMed Web of Science ®Google Scholar
• AndersonFDGibbonsWPortmanDSafety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiolContraception200673322923416472561
   PubMed Web of Science ®Google Scholar
• NakajimaSTArcherDFEllmanHEfficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe)Contraception2007751162217161118
   PubMed Web of Science ®Google Scholar
• Mircette® Study GroupAn open-label, multicenter, noncomparative safety and efficacy study of Mircette™, a low-dose estrogen-progestin oral contraceptiveAm J Obstet Gynecol19981791S2S89704812
   PubMed Web of Science ®Google Scholar
• Di CarloCGarganoVDe RosaNTommaselliGASpariceSNappiCEffects of estradiol valerate and dienogest on quality of life and sexual function according to ageGynecol Endocrinol2014301292592825366390
   PubMed Web of Science ®Google Scholar
• CarusoSAgnelloCRomanoMPreliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual lifeJ Sex Med20118102841285021810188
   PubMed Web of Science ®Google Scholar
• GrandiGXholliANapolitanoAPalmaFCagnacciAPelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot studyReprod Sci201522562663225394646
   PubMed Web of Science ®Google Scholar
• GraziottinAContraception containing estradiol valerate and dienogest–advantages, adherence and user satisfactionMinerva Ginecol201466547949525245997
   PubMedGoogle Scholar